Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways March 2026

US and European policymakers work to fit rapidly advancing AI and digital tools into established device regulatory frameworks; Boston Scientific's quest for widespread reimbursement of its Intracept chronic low back pain technology; Josh Makower on how to cope with FDA regulatory staff shortages; the EC's recent proposal to revise MDR and IVDR; negotations continue for MDUFA VI; and FDA launches Quality Management System Regulation.

Read Article